© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 5, 378-381,
March 7, 2001
© 2001 Oxford University Press
REPORT |
Metabolites of a Tobacco-Specific Lung Carcinogen in Nonsmoking Women Exposed to Environmental Tobacco Smoke
Affiliations of authors: K. E. Anderson, L. Murphy (Division of Epidemiology), S. G. Carmella, M. Ye, R. L. Bliss, S. S. Hecht (Comprehensive Cancer Center), C. Le (Division of Biostatistics), University of Minnesota, Minneapolis.
Correspondence to: Kristin E. Anderson, Ph.D., Division of Epidemiology, University of Minnesota, 1300 South Second St. #300, Minneapolis, MN 55454 (e-mail: anderson_k{at}epi.umn.edu).
Background: Environmental tobacco smoke (ETS) is associated with lung cancer in nonsmokers. Most epidemiologic studies find a higher risk for lung cancer in nonsmoking women married to smokers than in those married to nonsmokers. We measured metabolites of a tobacco-specific lung carcinogen in urine from healthy, nonsmoking women exposed to ETS. Methods: We recruited women and their partners through advertisements. Couples completed questionnaires on smoking history and demographics, and both partners provided 100 mL of urine; 23 women had male partners who smoked in the home (i.e., exposed women), and 22 women had male partners who did not smoke (i.e., unexposed women). Urine samples were analyzed for nicotine, for cotinine, for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and its glucuronide (NNAL-Gluc), as well as for creatinine. NNAL and NNAL-Gluc are metabolites of the tobacco-specific lung carcinogen 4-(meth-ylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Unpaired Student's t tests were conducted on log-transformed values. All statistical tests are two-sided. Results: Urinary levels of nicotine, cotinine, NNAL, and NNAL-Gluc were statistically significantly higher in exposed women than in unexposed women. Geometric means for these compounds in exposed versus unexposed women, respectively, were as follows: nicotine, 0.050 nmol/mg of creatinine (95% confidence interval [CI] = 0.033 to 0.076) versus 0.008 nmol/mg of creatinine (95% CI = 0.004 to 0.014); cotinine, 0.037 nmol/mg of creatinine (95% CI = 0.022 to 0.061) versus 0.007 nmol/mg of creatinine (95% CI = 0.004 to 0.011); NNAL, 0.013 pmol/mg of creatinine (95% CI = 0.007 to 0.024) versus 0.004 pmol/mg of creatinine (95% CI = 0.002 to 0.007); and NNAL-Gluc, 0.027 pmol/mg of creatinine (95% CI = 0.016 to 0.045) versus 0.004 pmol/mg of creatinine (95% CI = 0.003 to 0.006). Conclusions: Nonsmoking women exposed to ETS take up and metabolize the tobacco-specific lung carcinogen NNK, which could increase their risk of lung cancer. Within couples, the NNAL plus NNAL-Gluc level in exposed women compared with that of their smoking partners averaged 5.6%. Notably, epidemiologic studies have estimated the excess risk for lung cancer in nonsmoking women exposed to ETS as 1%2% of that in smokers.
This article has been cited by other articles:
![]() |
I. Stepanov and S. S. Hecht Detection and Quantitation of N'-Nitrosonornicotine in Human Toenails by Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 945 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Stark, K. Rohde, J. E. Maher, B. A. Pizacani, C. W. Dent, R. Bard, S. G. Carmella, A. R. Benoit, N. M. Thomson, and S. S. Hecht The Impact of Clean Indoor Air Exemptions and Preemption Policies on the Prevalence of a Tobacco-Specific Lung Carcinogen Among Nonsmoking Bar and Restaurant Workers Am J Public Health, August 1, 2007; 97(8): 1457 - 1463. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Stepanov, S. S. Hecht, B. Lindgren, P. Jacob III, M. Wilson, and N. L. Benowitz Relationship of Human Toenail Nicotine, Cotinine, and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol to Levels of These Biomarkers in Plasma and Urine Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1382 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Alberg, A. Kouzis, J. M. Genkinger, L. Gallicchio, A. E. Burke, S. C. Hoffman, M. Diener-West, K. J. Helzlsouer, and G. W. Comstock A Prospective Cohort Study of Bladder Cancer Risk in Relation to Active Cigarette Smoking and Household Exposure to Secondhand Cigarette Smoke Am. J. Epidemiol., March 15, 2007; 165(6): 660 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Chang, K. El-Bayoumy, I. Sinha, N. Trushin, B. Stanley, B. Pittman, and B. Prokopczyk 4-(Methylnitrosamino)-I-(3-Pyridyl)-1-Butanone Enhances the Expression of Apolipoprotein A-I and Clara Cell 17-kDa Protein in the Lung Proteomes of Rats Fed a Corn Oil Diet but not a Fish Oil Diet Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 228 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T Le A solution for the most basic optimization problem associated with an ROC curve Statistical Methods in Medical Research, December 1, 2006; 15(6): 571 - 584. [Abstract] [PDF] |
||||
![]() |
I. Stepanov, R. Feuer, J. Jensen, D. Hatsukami, and S. S. Hecht Mass Spectrometric Quantitation of Nicotine, Cotinine, and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol in Human Toenails Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2378 - 2383. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Hecht, S. G. Carmella, K.-A. Le, S. E. Murphy, A. J. Boettcher, C. Le, J. Koopmeiners, L. An, and D. J. Hennrikus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronides in the urine of infants exposed to environmental tobacco smoke. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 988 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Stepanov, S. S. Hecht, G. Duca, and I. Mardari Uptake of the Tobacco-Specific Lung Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-Butanone by Moldovan Children Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 7 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Thomas, L. A. Doyle, and M. J. Edelman Lung Cancer in Women: Emerging Differences in Epidemiology, Biology, and Therapy Chest, July 1, 2005; 128(1): 370 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. E. Tulunay, S. S. Hecht, S. G. Carmella, Y. Zhang, C. Lemmonds, S. Murphy, and D. K. Hatsukami Urinary Metabolites of a Tobacco-Specific Lung Carcinogen in Nonsmoking Hospitality Workers Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1283 - 1286. [Abstract] [Full Text] [PDF] |
||||
![]() |
S S Hecht Carcinogen derived biomarkers: applications in studies of human exposure to secondhand tobacco smoke Tob. Control, March 1, 2004; 13(90001): i48 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Anderson, J. Kliris, L. Murphy, S. G. Carmella, S. Han, C. Link, R. L. Bliss, S. Puumala, S. E. Murphy, and S. S. Hecht Metabolites of a Tobacco-Specific Lung Carcinogen in Nonsmoking Casino Patrons Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1544 - 1546. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Hennrikus, P R Pentel, and S D Sandell Preferences and practices among renters regarding smoking restrictions in apartment buildings Tob. Control, June 1, 2003; 12(2): 189 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Davey Smith Effect of passive smoking on health BMJ, May 15, 2003; 326(7398): 1048 - 1049. [Full Text] [PDF] |
||||
![]() |
M.L. Larsson, H-M. Loit, M. Meren, J. Polluste, A. Magnusson, K. Larsson, and B. Lundback Passive smoking and respiratory symptoms in the FinEsS Study Eur. Respir. J., April 1, 2003; 21(4): 672 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Willis and N. H. Colburn Molecular Targets for Cancer Prevention: A Meeting Review of the Third American Cancer Society-Schilling Research Conference Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 972 - 978. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Hecht Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer Carcinogenesis, June 1, 2002; 23(6): 907 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Hecht, M. Ye, S. G. Carmella, A. Fredrickson, J. L. Adgate, I. A. Greaves, T. R. Church, A. D. Ryan, S. J. Mongin, and K. Sexton Metabolites of a Tobacco-specific Lung Carcinogen in the Urine of Elementary School-aged Children Cancer Epidemiol. Biomarkers Prev., November 1, 2001; 10(11): 1109 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Anderson, S. S. Hecht, R. L. Bliss, and C. Le RESPONSE: Re: Metabolites of a Tobacco-Specific Lung Carcinogen in Nonsmoking Women Exposed to Environmental Tobacco Smoke J Natl Cancer Inst, October 17, 2001; 93(20): 1576 - 1577. [Full Text] [PDF] |
||||
![]() |
N. S. Chobanyan and A. K. Nersesyan Re: Metabolites of a Tobacco-Specific Lung Carcinogen in Nonsmoking Women Exposed to Environmental Tobacco Smoke J Natl Cancer Inst, October 17, 2001; 93(20): 1575a - 1576a. [Full Text] [PDF] |
||||









